New Jersey-based IGI Laboratories has entered into a packaging agreement with NeoStrata, to supply fully-packaged, ready-for-sale products to NeoStrata’s skin care products.
The collaboration of NeoStrata with IGI Laboratories represents NeoStrata’s commitment to partner with strong, reputable contract manufacturing and development organizations that contribute to the expansion of the product development pipeline.
NeoStrata VP of Operations Harry Salama said the agreement offers a beneficial synergy for both organizations.
IGI Laboratories President & CEO Charlie Moore said the partnership would enhance the company’s position as suppliers.
New Jersey-based NeoStrata develops and markets a comprehensive range of clinically-proven, dermatologist developed skin care brands including NeoStrata, Exuviance, CoverBlend, NeoCeuticals and NeoStrata Therapeutics. The advanced therapeutic and cosmetic dermatological products feature unsurpassed Polyhydroxy Acid technology to meet the needs of every skin type.
IGL Laboratories is a formulation and manufacturing company focused in the development and commercialization of products for the dermatology market.